Emerging Views On Emerging Markets: Cowen Group Healthcare Conference
This article was originally published in PharmAsia News
Executive Summary
PharmAsia News takes a closer look at presentations referencing emerging markets by Abbott, Amgen, Cardinal Health, Charles River Labs and J&J.
You may also be interested in...
China's Leading CROs Go On Shopping Spree To Become One-Stop Vendors
China's leading contract research organizations, Wuxi PharmaTech and ShangPharma, in a race to win over Big Pharma with integrated service platforms, announced separate deals Oct. 24 to expand into new strategic areas
Cross-Border Pollination? J&J China R&D Center Bonds With Indian Unit For Local Innovation
CHENNAI, India - Having established a device R&D innovation center in Suzhou, China, in July, Johnson & Johnson Medical Ltd. and DePuy, the $5 billion orthopaedics, spinal care and neurosciences franchise of Johnson & Johnson Company, have started working closely with their Indian counterparts in Mumbai to obtain local insights needed to develop products appropriate for the Asian marketplace
J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals